Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities
Net loss	$ (25,937)	$ (27,041)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	3,439	2,255
Operating lease right-of-use assets expense	5,294	4,602
Foreign currency remeasurement loss	763	3,026
Stock-based compensation	26,975	28,287
Deferred income taxes	(240)	(154)
Other	725	1,040
Change in value of earn-out and warrant liabilities	6,921	(6,754)
Changes in operating assets and liabilities:
Accounts receivable	(4,633)	(6,661)
Prepaid expenses and other current assets	1,663	(1,486)
Deferred contract costs and other assets	(5,637)	(8,436)
Accounts payable, accrued expenses, operating lease liabilities and other liabilities	(5,331)	(4,227)
Deferred revenue	9,282	8,656
Net cash provided by (used in) operating activities	13,284	(6,893)
Investing activities
Maturities of investments	1,292	180,837
Purchases of investments	(2,050)	(180,495)
Cash paid in business combinations and asset acquisitions, net of cash acquired	0	(18,574)
Capitalization of internal-use software	(988)	(1,165)
Purchase of property and equipment	(1,478)	(3,420)
Investment in notes	(1,000)	0
Net cash used in investing activities	(4,224)	(22,817)
Financing activities
Repurchase of common stock	(33,644)	(19,554)
Proceeds from stock option exercises	3,865	1,817
Repayments of finance leases	(30)	(23)
Net cash used in financing activities	(29,809)	(17,760)
Effect of exchange rates on cash	(653)	(2,966)
Net decrease in cash and cash equivalents	(21,402)	(50,436)
Cash and cash equivalents at beginning of period	227,188	268,217
Cash and cash equivalents at end of period	205,786	217,781
Supplemental disclosures of cash flow information
Income taxes paid	5,794	421
Contingent consideration in business combinations	$ 0	$ 5,635